Osteonecrosis of the Jaw - AAOMS Webinar
Sign up for the webinar by clicking here
In 2003-04, oral and maxillofacial surgeons were the first clinicians to recognize and report an increased number of patients presenting symptoms of osteonecrosis of the jaw, a non-healing exposed bone in the maxillofacial region. Further investigation revealed that many of these patients had been treated with IV and, to a lesser extent, oral bisphosphonates.
Osteonecrosis adversely affects quality of life and produces significant morbidity in afflicted patients. Oral and maxillofacial surgeons, who have been responsible for counseling, managing and treating a majority of these patients, believe it is important that their dental and medical colleagues, particularly those who are likely to treat patients undergoing bisphosphonate therapy, to understand the symptoms and characteristics of osteonecrosis; the risk factors for the disease among patients undergoing bisphosphonate treatment for osteoporosis; treatment options for osteonecrosis; and possible steps to prevent the development of this disease. It is also important that dental and medical providers understand that patients at risk can also present with other common clinical conditions that should not be confused with osteonecrosis.
Plan to attend this important 90-minute, Webinar on Osteoporosis and Osteonecrosis, Wednesday, May 30, 2007, from 1:00 pm, Eastern Standard Time.
Educational Objectives
Upon completion of this session, the participants should be able to:
* Describe bone metabolism and the pathophysiology of osteoporosis
* Describe the role of bisphosphonates in the treatment of osteoporosis including their mechanism of action and how long they stay in bone
* Describe the pathophysiology of bisphosphonate-related osteonecrosis of the jaws (BRONJ) and define its presentation characteristics
* Identify patients presenting with BRONJ or the potential for BRONJ
* Recognize current treatment algorithms for the management of BRONJ and describe:
o How to address patients
o The general dentists' role in diagnosis and management
o The oral maxillofacial surgeons' role in diagnosis and management
In 2003-04, oral and maxillofacial surgeons were the first clinicians to recognize and report an increased number of patients presenting symptoms of osteonecrosis of the jaw, a non-healing exposed bone in the maxillofacial region. Further investigation revealed that many of these patients had been treated with IV and, to a lesser extent, oral bisphosphonates.
Osteonecrosis adversely affects quality of life and produces significant morbidity in afflicted patients. Oral and maxillofacial surgeons, who have been responsible for counseling, managing and treating a majority of these patients, believe it is important that their dental and medical colleagues, particularly those who are likely to treat patients undergoing bisphosphonate therapy, to understand the symptoms and characteristics of osteonecrosis; the risk factors for the disease among patients undergoing bisphosphonate treatment for osteoporosis; treatment options for osteonecrosis; and possible steps to prevent the development of this disease. It is also important that dental and medical providers understand that patients at risk can also present with other common clinical conditions that should not be confused with osteonecrosis.
Plan to attend this important 90-minute, Webinar on Osteoporosis and Osteonecrosis, Wednesday, May 30, 2007, from 1:00 pm, Eastern Standard Time.
Educational Objectives
Upon completion of this session, the participants should be able to:
* Describe bone metabolism and the pathophysiology of osteoporosis
* Describe the role of bisphosphonates in the treatment of osteoporosis including their mechanism of action and how long they stay in bone
* Describe the pathophysiology of bisphosphonate-related osteonecrosis of the jaws (BRONJ) and define its presentation characteristics
* Identify patients presenting with BRONJ or the potential for BRONJ
* Recognize current treatment algorithms for the management of BRONJ and describe:
o How to address patients
o The general dentists' role in diagnosis and management
o The oral maxillofacial surgeons' role in diagnosis and management
Comments